RE
MYOV

RBC Europe’s Myovant Sciences Ltd. MYOV Stock Holding History

RBC Europe’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,250
Closed -$31.6K – 1190
2020
Q3 		$31.6K Hold
2,250
– – ﹤0.01% 557
2020
Q2 		$46.4K Sell
2,250
-750
-25% -$10.2K ﹤0.01% 459
2020
Q1 		$22.6K Buy
3,000
+750
+33% +$8.41K ﹤0.01% 535
2019
Q4 		$34.9K Buy
+2,250
New +$22.7K ﹤0.01% 533

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return

RBC Europe's MYOV Position: Q4 2020 in Review

RBC Europe sold out of Myovant Sciences Ltd. (MYOV) in Q4 2020, closing a stake of 2,250 shares — an estimated $31.6K sold.

RBC Europe first reported a position in MYOV in Q4 2019 and held it in 4 quarters. The position peaked at $46.4K in Q2 2020. 105 funds tracked by Wall St. Rank hold MYOV as of Q4 2020.

  • RBC Europe reported no remaining Myovant Sciences Ltd. position as of Q4 2020 after selling out during the quarter.
  • RBC Europe sold 2,250 Myovant Sciences Ltd. shares in Q4 2020, an estimated $31.6K.
  • RBC Europe first reported a position in Myovant Sciences Ltd. in Q4 2019 and held it in 4 quarters.
  • RBC Europe's Myovant Sciences Ltd. position peaked at $46.4K in Q2 2020.
  • 105 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2020.

Based on RBC Europe's 13F filing for Q4 2020, filed 9 Nov 2023.